Indian Govt. Clears Crucial HIV Drug For Children.
- Few months before Cipla stopped selling the previous syrup formulation for children to the NACO, stating the reason that it has not received payments from govt.
- This issue came into light when hundreds of children living with HIV have now written to Prime Minister Narendra Modi, Finance Minister Arun Jaitley and Health Minister JP Nadda asking for their urgent intervention.
- Cipla is one of the top pharmaceutical companies in India.
- Two forms of drugs are available the first is tablet form and the other is in syrup form(Lopinavir syrup).
- The tablets can be consumed by adults easily for children it is difficult so the syrup form becomes friendly for them.
- The unavailability of child friendly drug in market due to lack of production from CIPLA has made thousands of children living with HIV in India are reported to be at risk because according to Médecins Sans Frontières (MSF) points out, “HIV infection progresses more quickly in children than adults.
On May 25, an expert committee of the Central Drugs Standard Control Organization (CDSCO) finally granted approval in India, to the pellet formulation of the HIV drug lopinavir/ritonavir (LPV/r), seen as heat stable and easy to administer, especially compared to the previous formulation of a syrup.
National AIDS Control Programme (NACO)
- The National AIDS Control Organisation (NACO), established in 1992, is a division of India’s Ministry of Health and Family Welfarethat provides leadership to HIV/AIDS control programme in India through 35 HIV/AIDS Prevention and Control Societies.
- n 2010, NACO approved the TeachAIDS curriculum for use in India, an innovation which represented the first time that HIV/AIDSeducation could be provided in a curriculum which did not need to be coupled with sex education.